Neuropathic pain (pain associated with lesions or dysfunction of nervous system) is
relatively common, occurring in about 1% of the population. Studies in animal models …

Neuropathic pain, pain arising as a direct consequence of a lesion or disease affecting the
somatosensory system, is relatively common, occurring in about 1% of the population …

Neuropathic pain is a debilitating form of treatment resistant chronic pain and responds
poorly to the clinically available therapies. Studies from animal models of neuropathic pain …

Pharmacotherapy, the main treatment option for neuropathic pain, remains a major clinical
challenge. The most commonly studied drug classes in the context of neuropathic pain …

Advances in the characterization of pain signaling in recent years indicate that distinct
neurophysiological and neurochemical mechanisms contribute to pain arising from injury to …

Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology
Pharmacology and treatment of neuropathic pains : Current Opinion in Neurology Log in or …

Neuropathic pain can result from injury to, or disease of the nervous system. It is notoriously
difficult to treat. Peripheral nerve injury promotes Schwann cell activation and invasion of …

Neuropathic pain develops from a lesion or disease affecting the somatosensory system.
Translational investigations of neuropathic pain by using different animal models reveal that …

Refractory neuropathic pain can be devastating to a patient's quality of life. Ideally, the
primary goal of therapy would be to prevent the pain, yet even the most appropriate …

Current drugs reduce neuropathic pain and improve mood and quality of life. However, as
single agents they are limited by incomplete efficacy and dose-limiting adverse effects …